Abstract
Posttraumatic stress disorder (PTSD) is a complex psychiatric condition that has generated much attention in the neuroimaging literature. A neurocircuitry model supporting fronto-limbic dysfunction as a major player in facilitating clinical symptoms of PTSD is well-characterized; however, recent literature suggests that network-based approaches may provide additional insight into neural dysfunction in PTSD. Our analysis uses resting-state neuroimaging scans of 1063 adults from the PGC-ENIGMA PTSD Consortium to investigate a network-based model of functional connectivity in PTSD. With a novel, resolution limit-free community detection approach, 16 communities corresponding to functionally meaningful networks were detected with high quality. After group-level community detection, participants were classified into three groups (PTSD, n=418, trauma-exposed controls without PTSD, n=434, and non-trauma exposed healthy controls, n=211). Individual network connectivity metrics were calculated, including whole-brain, default mode network, and central executive network participation coefficient and connectivity strength. Linear mixed effects models revealed group differences in the whole-brain, default mode, and central executive network participation coefficient and connectivity strength such that individuals with PTSD demonstrated overall greater values. We also described sex differences such that males demonstrate greater whole-brain participation coefficient vs. females and females demonstrate greater default mode network connectivity strength vs. males. Our results suggest that PTSD in adults is associated with reduced specialization and enhanced inter-module communication throughout the brain network, which may contribute to inefficient information processing and poor emotional regulation. This study presents a novel use of resolution limit-free community detection in a large PTSD sample, revealing robust differences in resting-state network topology.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Research in this publication was supported by the National Institute of Mental Health and the National Institutes of Health under awards T32MH018931 31, F31MH122047 and T32GM007507. PGC-ENGIMA Project Funding Acknowledgements: Congressionally Directed Medical Research Program (W81XWH 08 2 0038: PI Sponheim), the Department of Veterans Affairs, Rehabilitation R&D Program (I01RX000622: PI Sponheim, IK2RX002922: PI Disner); National Institute of Mental Health (R21MH112956: PI Kaufman; K23MH090366 01: PI Bruce; K01MH118467: PI Lebois; MH119132 and MH097784: PI Cisler; R01MH11167101 and VISN6 MIRECC: PI Morey); VA Merit (1I01RX00038901 and 1I01CX00074801A1; PI Morey); Grady Trauma Project supported through MH098212; MH071537; M01RR00039; UL1TR000454; HD071982; HD085850; MH101380; Narsad Young Investigator; German Research Foundation (DA 1222/4 1: PI Daniels, WA 1539/8 2: PI Walter); EU Rosalind Franklin Fellowship Program (Daniels); German National Merit Foundation (Sierk). The COPTSD study was funded by a Hospital Clinical Research Program (Promoteur CHRU de Tours). We acknowledge the Fondation Pierre Deniker and the SFR FED4226 Neuroimagerie Fonctionnelle for their financial support. This study was also supported by a postgraduate scholarship from the French Ministry of Higher Education, Research and Innovation awarded to YQ. Canadian Institutes of Health Research (Densmoore); and Canadian Institute for Military and Veteran Health Research (Densmoore and Lanius).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Study procedures for the PGC-ENIGMA PTSD working group were evaluated by the Duke University Health System Institutional Review Board for Clinical Investigations (Chair - Donna G. Kessler, PhD). This protocol (IRB Pro00079963) was approved on 1-04-2017 at 12:00 AM EST, and ruled exempt by the Duke Health IRB (lead site for PGC-ENIGMA PTSD working group)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data from this analysis may be made available upon request from the PGC-ENGIMA PTSD consortium.
